Log In
BCIQ
Print this Print this
 

Thrombopoietin (TPO) receptor (CD110) (Mpl)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Thrombopoietin (TPO) receptor (CD110) (Mpl)

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 2 Approved, 2 Phase III, 2 Phase III, 1 Phase III, 1 Phase II, 2 Phase II, 1 Phase I, 1
Phase of DevelopmentPhase IPhase IIPhase IIIApprovedMarketed
Autoimmune

-

-

1

-

2

Cancer

-

1

1

-

-

Hematology

1

2

2

2

1




 Products Targeting Thrombopoietin (TPO) receptor (CD110) (Mpl)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$17,054.9M

$14,820.9M

$2,234.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/28/2014

$17,034.0M

$14,800.0M

$2,234.0M

04/11/2011

$20.9M

$20.9M

0

Get a free BioCentury Trial today